A 15-year study shows that the drug pergolide is an effective treatment for pituitary pars intermedia dysfunction.
Dechra, a global leader in veterinary specialty care, today announced the FDA approval of Zygolide ® (pergolide tablets), the first FDA-approved bioequivalent option indicated for the control of ...
Your Horse on MSN
Everything you need to know about Cushing’s disease in horses
Equine Cushing’s disease is one of the most common disease syndromes to affect horse health, according to the National Equine Health Survey in 2018*. It is estimated that 20% of horses and ponies over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results